HONG KONG and BUFFALO, New York, Dec. 17, 2014 /PRNewswire/ — Kinex Pharmaceuticals announced today that Mr. Flint Besecker has been appointed Chief Operating Officer of the company. Mr. Besecker will have additional responsibility over Kinex’s emerging global operating platforms in addition to all corporate business matters reporting to Kinex’s Chief Executive Officer, Dr. Johnson Lau. More recently, Flint served as Chief Business Officer and has been Executive Vice-President and Chief Financial Officer of Kinex since July 2013 and a Board member since 2011.
Mr. Besecker’s expanded role underscores Kinex’s business strategy to continue expanding its global footprint with existing operations in the United States and in Asia. "Flint has contributed significantly to the business, strategic and operational development of Kinex since joining the Executive rank. His prior Fortune 500 execution experience along with capital market and global experience will be important for our long term global growth strategy." Dr. Lau said. "We are delighted to have his commitment to further expand his role, and his depth of experience will contribute to our commitments to build value for shareholders."
Mr. Michael Murphy, Chairman of Corporate Governance and Nominating Committee, stated, "Flint brings a wealth of operational experience to the company, and he complements the management team very well. The Board is confident that the management team, with Flint in his new role, will continue driving the company’s core business to success, including our ongoing global expansion."
In accepting his appointment as the Chief Operating Officer, Mr. Besecker stated, "I believe we have an enormous market opportunity across multiple continents to positively influence next generation cancer treatment for patients. We have a strong oncology drug pipeline and an operational strategy to drive this global change and increase access to care. I am excited to support the vision of the leadership team and assist the company to evolve as a global oncology specialty pharmaceutical company."
Mr. Besecker is a 20-year veteran of the healthcare industry, bringing a wealth of executive experience in all facets of healthcare. Some of his previous roles included CEO of the Center for Hospice and Palliative Care, Founder and Board Chair of Care Investment Trust, founder and President of CIT Healthcare, Managing Director of GE Healthcare Financial Services and Chief Risk Officer of Heller Healthcare. He has also held numerous Board positions in both private and public healthcare companies and is a former CPA in New York State.